Division of Pediatric Hematology/Oncology

Clinical Trials

Renal

• AREN0321: Phase III—Treatment of high risk renal tumors
  Principal investigator: Cindy Schwartz, MD

• AREN03B2—Renal tumors classification, biology and banking study
  Principal investigator: Cindy Schwartz, MD

• AREN0532: Phase III—Treatment for very low, low and standard risk, favorable histology Wilms tumor
  Principal investigator: Cindy Schwartz, MD

• AREN0533: Phase III—Treatment of newly diagnosed, higher risk, favorable histology Wilms tumor
  Principal investigator: Cindy Schwartz, MD

• LTE4941L—National Wilms tumor late effects study
  Principal investigator: Cindy Schwartz, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back